Anti-Obesity Drugs Market Set to Surge, Projected to Reach USD 37.94 Billion by 2032
The Anti-Obesity Drugs Market Growth is on an unprecedented growth trajectory, with projections indicating a rise from USD 6.15 billion in 2024 to USD 37.94 billion by 2032, reflecting a Compound Annual Growth Rate (CAGR) of 25.5%.
Request a Free Sample of the Report to Gain In-Depth...